Skip to main content

Peer Review reports

From: TG2 as a novel breast cancer prognostic marker promotes cell proliferation and glycolysis by activating the MEK/ERK/LDH pathway

Original Submission
2 Jun 2021 Submitted Original manuscript
16 Jul 2021 Reviewed Reviewer Report
18 Jul 2021 Reviewed Reviewer Report
2 Sep 2021 Author responded Author comments - Youjun Li
Resubmission - Version 2
2 Sep 2021 Submitted Manuscript version 2
9 Dec 2021 Reviewed Reviewer Report
16 Dec 2021 Reviewed Reviewer Report
20 Mar 2022 Author responded Author comments - Youjun Li
Resubmission - Version 3
20 Mar 2022 Submitted Manuscript version 3
10 Apr 2022 Author responded Author comments - Youjun Li
Resubmission - Version 4
10 Apr 2022 Submitted Manuscript version 4
14 Apr 2022 Author responded Author comments - Youjun Li
Resubmission - Version 5
14 Apr 2022 Submitted Manuscript version 5
22 Apr 2022 Author responded Author comments - Youjun Li
Resubmission - Version 6
22 Apr 2022 Submitted Manuscript version 6
26 May 2022 Reviewed Reviewer Report
Resubmission - Version 7
Submitted Manuscript version 7
Publishing
24 Nov 2022 Editorially accepted
5 Dec 2022 Article published 10.1186/s12885-022-10364-2

You can find further information about peer review here.

Back to article page